Updated:
Cascadian Therapeutics, Inc.
Cascadian Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001412067, and its reported...
Overview
Cascadian Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001412067, and its reported industry is Services-Commercial Physical & Biological Research. In 10-K filed on 2018-03-08, it reported net income of USD -56,934,000; total assets of USD 120,825,000 for the fiscal period ended 2017-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Cascadian Therapeutics, Inc.
- Former names in filing history
- Oncothyreon Inc. (2007-09-14 to 2016-06-09); Biomira CORP (2007-09-12 to 2007-09-27)
- Classification
- Company
- Industry (SIC)
- 8731 — Services-Commercial Physical & Biological Research
- Headquarters
- Seattle, WA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001412067
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|
| FY2017USD | -$56.9M | $120.8M | $16.8M | -$50.0M | |
| FY2016USD | -$57.7M | $83.3M | $13.7M | — | |
| FY2015USD | -$32.6M | $96.6M | $27.9M | -$28.9M | |
| FY2014USD | -$50.0M | $103.4M | $10.5M | -$48.4M |
FY2015. Operating cash flow: shown as originally filed; later filings report different values for the same periods.
FY2014. Net income, Total assets: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | FORM 8-K | ||
| 10-K | 10-K | ||
| 8-K | 8-K | ||
| SC 13G | — | Form SC 13G | |
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | QUARTERLY REPORT | ||
| 8-K | CURRENT REPORT | ||
| 10-Q | QUARTERLY REPORT | ||
| 8-K | CURRENT REPORT | ||
| 8-K | FORM 8-K | ||
| 10-Q | 10-Q |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Cascadian Therapeutics, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.